Young Journalists Club | Latest news of Iran and world

19 September 2017 - 18:11
News ID: 4615
Iran » Iran
Publish Date: 15:22 - 13 July 2014
Tehran, YJC. Iranian researchers have introduced a new treatment for Benign prostatic hyperplasia.

Hossein Qenaati, MD and head of Imam Khomeini (RA) Imaging Center and an expert in interventional radiology, told IRIB that the new method rules out the need for surgery, and simply by blocking the artery for a shrink in prostate size, Mehr News Agency reports.

In prostatic artery embolization, a catheter is fed through the femoral artery to the prostatic artery on both sides of the prostate. Once the catheter is placed as close to the prostate as possible, it delivers microscopic spheres (Embozene) that block some of the blood supply to the gland, causing it to shrink, Qenaati was quoted to say.

"Currently patients suffering from Benign Prostatic Hyperplasia (BPH) or benign prostatic hypertrophy (technically correct term to describe the case) with failed attempts in medication with other therapies are candidates for prostatic artery embolization,” added he, and called all urologists to refer patients to the hospital for treatment through the new method.

"The new method is currently expensive, since the equipment used is imported; we expect to see the costs of the method decreased by insurance provisions,” he said.

Benign prostatic hyperplasia affects men with fist symptoms appearing in 40. 80 per cent of men above 70 suffer from the disease. Symptoms that adversely affect quality of life include increased urinary frequency, a sudden urge to urinate, frequent nighttime urination, weak stream, and feeling like the bladder is not empty.

Your Comment
Name:
Email:
* Comment:
* captcha: